Elias Stratigouleas, MD
Otolaryngology · Tucson, AZNPI 1043268741
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Stryker at 32.8% of the total. Reporting peaked in 2022 at $974 and has fallen 53.5% since, to $453 in 2025.
Across 79 payments — averaging $32.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$842
- Sanofi$309
- Aerin Medical Inc.$283
- AbbVie$246
- Regeneron Healthcare Solutions, Inc.$236
- GSK$222
- plus $429 from 9 others
What the payments were for
- Food & beverage$2,568100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 13 | $842 |
| Sanofi | 13 | $309 |
| Aerin Medical Inc. | 6 | $283 |
| AbbVie | 6 | $246 |
| Regeneron Healthcare Solutions, Inc. | 12 | $236 |
| GSK | 12 | $222 |
| Acclarent, Inc | 4 | $113 |
| Optinose US, Inc. | 4 | $78 |
| Medtronic | 2 | $72 |
| Carestream Dental, LLC | 2 | $62 |
| Merck | 1 | $28 |
| Kaleo, Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $23 |
| Amgen | 1 | $15 |
| Cochlear Americas | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,568 in reported general payments places this provider in the 65th percentile of 150 otolaryngology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $79,704 |
| Dexlansoprazole DrDexlansoprazole | 53 | $14,604 |
| Famotidine | 709 | $13,476 |
| Azelastine Hcl | 309 | $12,092 |
| Ipratropium Bromide | 181 | $6,367 |
| Pantoprazole Sodium | 359 | $5,026 |
| Fluticasone Propionate | 156 | $3,715 |
| Montelukast Sodium | 201 | $2,111 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 12 | $1,556 |
| Mometasone Furoate | 50 | $1,431 |
| Fluocinolone Acetonide Oil | 29 | $1,396 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 91 | $1,101 |
| Promethazine Hcl | 65 | $1,022 |
| Levocetirizine Dihydrochloride | 69 | $1,000 |
| Ofloxacin | 31 | $750 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Tucson
- Eugene ChangTucson$44K
- Shethal BearellyTucson$11K
- Afshin EmamiTucson$8K
- Matthew GroysmanTucson$6K
- Adam RayTucson$5K
- Christopher leTucson$5K
- John ChastainTucson$4K
- Robert DeanTucson$4K
- David HuTucson$4K
- Claire GleadhillTucson$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.